Neurobiology of Disease, 0969-9961

Tidskrift

Fler filtreringsmöjligheter
  1. 2020
  2. Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease

    Joana B. Pereira, Sara Hall, Mattis Jalakas, Michel J. Grothe, Olof Strandberg, Erik Stomrud, Eric Westman, Danielle van Westen & Oskar Hansson, 2020 jun, I : Neurobiology of Disease. 139, 104831.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Cerebrospinal fluid neurogranin in an inducible mouse model of neurodegeneration: A translatable marker of synaptic degeneration

    Kina Höglund, Nathalie Schussler, Hlin Kvartsberg, Una Smailovic, Gunnar Brinkmalm, Victor Liman, Bruno Becker, Henrik Zetterberg, Angel Cedazo-Minguez, Shorena Janelidze, Isabel A. Lefevre, Stéphanie Eyquem, Oskar Hansson & Kaj Blennow, 2020 feb, I : Neurobiology of Disease. 134, 104645.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. 2019
  5. Heritability and genetic variance of dementia with Lewy bodies

    Rita Guerreiro, Elisabet Londos, Jose Bras & International Parkinson's Disease Genomics Consortium (IPDGC) International Parkinson's Disease Genomics Consortium (IPDGC), 2019, I : Neurobiology of Disease. 127, s. 492-501 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Leptin deficiency reverses high metabolic state and weight loss without affecting central pathology in the R6/2 mouse model of Huntington's disease

    Marie Sjögren, Rana Soylu-Kucharz, Unali Dandunna, Tiberiu Loredan Stan, Michele Cavalera, Åsa Sandelius, Henrik Zetterberg & Maria Björkqvist, 2019, I : Neurobiology of Disease. 132, 104560.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease

    Clarissa Ferolla Mendonça, Magdalena Kuras, Fábio César Sousa Nogueira, Indira Plá, Tibor Hortobágyi, László Csiba, Miklós Palkovits, Éva Renner, Péter Döme, György Marko-Varga, Gilberto B. Domont & Melinda Rezeli, 2019, I : Neurobiology of Disease. 130, 104509.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. 2018
  9. Parkinson's disease-like burst firing activity in subthalamic nucleus induced by AAV-α-synuclein is normalized by LRRK2 modulation

    Michael Aagaard Andersen, Kenneth Vielsted Christensen, Lassina Badolo, Garrick Paul Smith, Ross Jeggo, Poul Henning Jensen, Kathrine Just Andersen & Florence Sotty, 2018 aug, I : Neurobiology of Disease. 116, s. 13-27 15 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Prion-like seeding and nucleation of intracellular amyloid-β

    Tomas T. Olsson, Oxana Klementieva & Gunnar K. Gouras, 2018 maj 1, I : Neurobiology of Disease. 113, s. 1-10 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. 2017
  12. Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration

    Itzia Jimenez, Michael Jewett, Ashmita Tontanahal, Marina Romero-Ramos & Maria Swanberg, 2017 okt 1, I : Neurobiology of Disease. 106, s. 279-290 12 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. Amplifying mitochondrial function rescues adult neurogenesis in a mouse model of Alzheimer's disease

    Kevin Richetin, Manon Moulis, Aurélie Millet, Macarena S. Arràzola, Trinovita Andraini, Jennifer Hua, Noélie Davezac, Laurent Roybon, Pascale Belenguer, Marie Christine Miquel & Claire Rampon, 2017 jun 1, I : Neurobiology of Disease. 102, s. 113-124 12 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. Functional validation of ABHD12 mutations in the neurodegenerative disease PHARC

    Angèle Tingaud-Sequeira, Demetrio Raldúa, Julie Lavie, Guilaine Mathieu, Magali Bordier, Anja Knoll-Gellida, Pierre Rambeau, Isabelle Coupry, Michèle André, Eva Malm, Claes Möller, Sten Andreasson, Nanna D. Rendtorff, Lisbeth Tranebjærg, Michel Koenig, Didier Lacombe, Cyril Goizet & Patrick J. Babin, 2017 feb 1, I : Neurobiology of Disease. 98, s. 36-51 16 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. Gene therapy for Parkinson's disease: Disease modification by GDNF family of ligands

    Deniz Kirik, Erik Cederfjäll, Glenda Halliday & Petersén, 2017 jan 1, I : Neurobiology of Disease. 97, s. 179-188 10 s.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  16. 2016
  17. Dissociation of metabolic and hemodynamic levodopa responses in the 6-hydroxydopamine rat model

    Renata P. Lerner, Zisis Bimpisidis, Stergiani Agorastos, Sandra Scherrer, Stephen L. Dewey, Angela Cenci Nilsson & David Eidelberg, 2016 dec 1, I : Neurobiology of Disease. 96, s. 31-37 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Validation of an improved scale for rating L-DOPA-induced dyskinesia in the mouse and effects of specific dopamine receptor antagonists

    Irene Sebastianutto, Natallia Maslava, Corey R. Hopkins & Angela Cenci Nilsson, 2016 dec 1, I : Neurobiology of Disease. 96, s. 156-170 15 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. Dramatic differences in susceptibility to L-DOPA-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion

    Francesco Bez, Veronica Francardo & Angela Cenci Nilsson, 2016 okt 1, I : Neurobiology of Disease. 94, s. 213-225 13 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Platelet-derived growth factor-BB has neurorestorative effects and modulates the pericyte response in a partial 6-hydroxydopamine lesion mouse model of Parkinson's disease

    Thomas Padel, Ilknur Ozen, Jordi Boix, Marco Barbariga, Abderahim Gaceb, Michaela Roth & Gesine Paul, 2016 okt 1, I : Neurobiology of Disease. 94, s. 95-105 11 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Translational approach for gene therapy in epilepsy: Model system and unilateral overexpression of neuropeptide Y and Y2 receptors.

    Litsa Nikitidou, Esbjörn Melin, Søren H Christiansen, Casper R Gøtzsche, Alessandra Cifra, David P D Woldbye & Merab Kokaia, 2016, I : Neurobiology of Disease. 86, nov 19, s. 52-61

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. 2015
  23. A cell culture model for monitoring α-synuclein cell-to-cell transfer.

    Juan F Reyes, Tomas Olsson, Jennifer T Lamberts, Michael J Devine, Tilo Kunath & Patrik Brundin, 2015, I : Neurobiology of Disease. 77, Jul 16, s. 266-275

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Characterisation of immune cell function in fragment and full-length Huntington's disease mouse models.

    Ulrike Träger, Ralph Andre, Anna Magnusson-Lind, James R C Miller, Colúm Connolly, Andreas Weiss, Stephan Grueninger, Edina Silajdzic, Donna L Smith, Blair R Leavitt, Gillian P Bates, Maria Björkqvist & Sarah J Tabrizi, 2015, I : Neurobiology of Disease. 73, s. 388-398

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. Cystamine/cysteamine rescues the dopaminergic system and shows neurorestorative properties in an animal model of Parkinson's disease.

    G Cisbani, Janelle Drouin-Ouellet, C Gibrat, M Saint-Pierre, M Lagacé, S Badrinarayanan, M H Lavallée-Bourget, J Charest, A Chabrat, L Boivin, M Lebel, M Bousquet, M Lévesque & F Cicchetti, 2015, I : Neurobiology of Disease. 82, s. 430-444

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.

    Nishant Narayanan Vaikath, Nour K Majbour, Katerina E Paleologou, Mustafa T Ardah, Esther van Dam, Wilma D J van de Berg, Shelley L Forrest, Laura Parkkinen, Wei-Ping Gai, Nobutaka Hattori, Masashi Takanashi, Seung-Jae Lee, David M A Mann, Yuzuru Imai, Glenda M Halliday, Jia-Yi Li & Omar M A El-Agnaf, 2015, I : Neurobiology of Disease. 79, s. 81-99

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. Inflammation without neuronal death triggers striatal neurogenesis comparable to stroke.

    Katie Chapman, Ruimin Ge, Emanuela Monni, Jemal Tatarishvili, Henrik Ahlenius, Andreas Arvidsson, Christine Ekdahl, Olle Lindvall & Zaal Kokaia, 2015, I : Neurobiology of Disease. 83, Aug 20, s. 1-15

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease.

    Ulrika Nordström, Geneviève Beauvais, Anamitra Ghosh, Baby Chakrapani Pulikkaparambil Sasidharan, Martin Lundblad, Julia Fuchs, Rajiv L Joshi, Jack W Lipton, Andrew Roholt, Satish Medicetty, Timothy N Feinstein, Jennifer Steiner, Martha L Escobar Galvis, Alain Prochiantz & Patrik Brundin, 2015, I : Neurobiology of Disease. 73, s. 70-82

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. Reconstruction of brain circuitry by neural transplants generated from pluripotent stem cells.

    Lachlan Thompson & Anders Björklund, 2015, I : Neurobiology of Disease. 79, Apr 22, s. 28-40

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  30. Rodent models of impulsive compulsive behaviors in Parkinson's disease: how far have we reached?

    Angela Cenci Nilsson, Veronica Francardo, Sean S O'Sullivan & Hanna Lindgren, 2015, I : Neurobiology of Disease. 82, aug 29, s. 561-573

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  31. Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function.

    Kerstin Buck, Natalie Landeck, Ayse Ulusoy, Nour K Majbour, Omar M A El-Agnaf & Deniz Kirik, 2015, I : Neurobiology of Disease. 78, Mar 25, s. 100-114

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. Spreading of α-synuclein in the face of axonal transport deficits in Parkinson's disease: A speculative synthesis.

    Jennifer T Lamberts, Erin Hildebrandt & Patrik Brundin, 2015, I : Neurobiology of Disease. 77, Jul 15, s. 276-283

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  33. 2014
  34. Enriched housing down-regulates the Toll-like receptor 2 response in the mouse brain after experimental stroke.

    Miriana Quattromani, Pierre Cordeau, Karsten Ruscher, Jasna Kriz & Tadeusz Wieloch, 2014, I : Neurobiology of Disease. 66, Mar 6, s. 66-73

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. GABAA receptor dephosphorylation followed by internalization is coupled to neuronal death in in vitro ischemia.

    Miranda Mele, Luís Ribeiro, Ana Inacio, Tadeusz Wieloch & Carlos B Duarte, 2014, I : Neurobiology of Disease.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. Optogenetic inhibition of chemically induced hypersynchronized bursting in mice.

    Fredrik Berglind, Marco Ledri, Andreas Toft Sørensen, Litsa Nikitidou, Miriam Melis, Pascal Bielefeld, Deniz Kirik, Karl Deisseroth, My Andersson & Merab Kokaia, 2014, I : Neurobiology of Disease. 65, s. 133-141

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation.

    Eunju Shin, Carlo Lisci, Elisabetta Tronci, Camino Fidalgo, Roberto Stancampiano, Anders Björklund & Manolo Carta, 2014, I : Neurobiology of Disease. 62, s. 233-240

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. 2013
  39. Comparison of rating scales used to evaluate L-DOPA-induced dyskinesia in the 6-OHDA lesioned rat

    Ludivine S Breger, Stephen B Dunnett & Emma L Lane, 2013 feb, I : Neurobiology of Disease. 50, s. 142-50 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP.

    Christian Hansen, Tomas Björklund, Géraldine Petit, Martin Lundblad, Reena Murmu, Patrik Brundin & Jia-Yi Li, 2013, I : Neurobiology of Disease. 56C, April,30, s. 145-155

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  41. Efficient expansion and dopaminergic differentiation of human fetal ventral midbrain neural stem cells by midbrain morphogens

    Diogo Ribeiro, Rocio Laguna Goya, Geeta Ravindran, Romina Vuono, Clare L. Parish, Claire Foldi, Tobias Piroth, Shanzheng Yang, Malin Parmar, Guido Nikkhah, Jens Hjerling-Leffler, Olle Lindvall, Roger Barker & Ernest Arenas, 2013, I : Neurobiology of Disease. 49, s. 118-127

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. Grafted human neural stem cells enhance several steps of endogenous neurogenesis and improve behavioral recovery after middle cerebral artery occlusion in rats.

    Yutaka Mine, Jemal Tatarishvili, Koichi Oki, Emanuela Monni, Zaal Kokaia & Olle Lindvall, 2013, I : Neurobiology of Disease. 52, Dec.,28, s. 191-203

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  43. Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease

    Fabia Febbraro, Gurdal Sahin, Aina Farran, Sofia Soares, Poul H. Jensen, Deniz Kirik & Marina Romero-Ramos, 2013, I : Neurobiology of Disease. 56, s. 47-58

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  44. 2012
  45. Combined gene overexpression of neuropeptide Y and its receptor Y5 in the hippocampus suppresses seizures

    Casper R. Gotzsche, Litsa Nikitidou, Andreas Toft Sörensen, Mikkel V. Olesen, Gunnar Sorensen, Soren H. O. Christiansen, Mikael Ängehagen, David P. D. Woldbye & Merab Kokaia, 2012, I : Neurobiology of Disease. 45, 1, s. 288-296

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. Dysregulated dopamine storage increases the vulnerability to alpha-synuclein in nigral neurons

    Ayse Ulusoy, Tomas Björklund, Kerstin Buck & Deniz Kirik, 2012, I : Neurobiology of Disease. 47, 3, s. 367-377

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  47. In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to l-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels

    Flora Mela, Matteo Marti, Simone Bido, Angela Cenci Nilsson & Michele Morari, 2012, I : Neurobiology of Disease. 45, 1, s. 573-582

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  48. Key factors determining the efficacy of gene therapy for continuous DOPA delivery in the Parkinsonian brain

    Erik Cederfjäll, Gurdal Sahin & Deniz Kirik, 2012, I : Neurobiology of Disease. 48, 2, s. 222-227

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  49. Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.

    Mickael Decressac, Bengt Mattsson, Martin Lundblad, P Weikop & Anders Björklund, 2012, I : Neurobiology of Disease. 45, 3, s. 939-953

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  50. Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease.

    Eunju Shin, Joanna Garcia, Christian Winkler, Anders Björklund & Manolo Carta, 2012, I : Neurobiology of Disease. 47, 3, s. 393-406

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  51. Special Issue: Viral delivery of genes: new frontiers Introduction

    Jeffrey H. Kordower & Deniz Kirik, 2012, I : Neurobiology of Disease. 48, 2, s. 151-152

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  52. 2011
  53. Apoptosis-inducing factor mediates dopaminergic cell death in response to lps-induced inflammatory stimulus Evidence in Parkinson's disease patients.

    Miguel Burguillos Garcia, N Hajji, E Englund, A Persson, Angela Cenci Nilsson, A Machado, J Cano, B Joseph & J L Venero, 2011, I : Neurobiology of Disease. 41, s. 177-188

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  54. Cleavage of the vesicular glutamate transporters under excitotoxic conditions

    Andrea C. Lobo, Joao R. Gomes, Tatiana Catarino, Miranda Mele, Pedro Fernandez, Ana Inacio, Ben A. Bahr, Armanda E. Santos, Tadeusz Wieloch, Ana Luisa Carvalho & Carlos B. Duarte, 2011, I : Neurobiology of Disease. 44, 3, s. 292-303

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  55. Gastrointestinal dysfunction contributes to weight loss in Huntington's disease mice.

    Jorien m van der Burg, Annika Winqvist, N Ahmad Aziz, Marion L C Maat-Schieman, Raymund A C Roos, Gillian P Bates, Patrik Brundin, Maria Björkqvist & Nils Wierup, 2011, I : Neurobiology of Disease. 44, s. 1-8

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  56. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.

    Veronica Francardo, Alessandra Recchia, Nataljia Popovic, Daniel Andersson, Hans Nissbrandt & Angela Cenci Nilsson, 2011, I : Neurobiology of Disease. 42, s. 327-340

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  57. 2010
  58. A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys.

    Daniella Rylander, Hanna Iderberg, Qin Li, Andrzej Dekundy, Jinlan Zhang, Hao Li, Ren Baishen, Wojciech Danysz, Erwan Bezard & Angela Cenci Nilsson, 2010, I : Neurobiology of Disease. 39, s. 352-361

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  59. Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis.

    Charlotte Soneson, Magnus Fontes, Yongxia Zhou, Vladimir Denisov, Jane S Paulsen, Deniz Kirik & Åsa Petersén, 2010, I : Neurobiology of Disease. 40, s. 531-543

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  60. 2009
  61. Increased levels of cocaine and amphetamine regulated transcript in two animal models of depression and anxiety.

    Sara Wiehager, Daniela I Beiderbeck, Susanne H M Gruber, Aram El-Khoury, Jackie Wamsteeker, Inga D Neumann, Åsa Petersén & Aleksander A Mathé, 2009, I : Neurobiology of Disease. 34, s. 375-380

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  62. 2008
  63. Increased metabolism in the R6/2 mouse model of Huntington's disease.

    Jorien m van der Burg, Karl Bacos, Nigel I Wood, Andreas Lindqvist, Nils Wierup, Ben Woodman, Jaclyn Wamsteeker, Ruben Smith, Tomas Deierborg, Michael J Kuhar, Gillian P Bates, Hindrik Mulder, Charlotte Erlanson-Albertsson, Jennifer Morton, Patrik Brundin, Åsa Petersén & Maria Björkqvist, 2008, I : Neurobiology of Disease. 29, 1, s. 41-51

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  64. In vivo gene delivery to proliferating cells in the striatum generated in response to a 6-hydroxydopamine lesion of the nigro-striatal dopamine pathway

    Dwain Morris-Irvin, Deniz Kirik, Anders Björklund & Lachlan Thompson, 2008, I : Neurobiology of Disease. 30, 3, s. 343-352

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  65. l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation

    B Picconi, V Paille, V Ghiglieri, V Bagetta, I Barone, Hanna Lindgren, G Bernardi, Angela Cenci Nilsson & P Calabresi, 2008, I : Neurobiology of Disease. 29, 2, s. 327-335

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  66. Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease.

    Emma Lane, Denis Soulet, L Vercammen, Angela Cenci Nilsson & Patrik Brundin, 2008, I : Neurobiology of Disease. 32, s. 220-228

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  67. 2007
  68. Nerve growth factor promotes survival of new neurons in the adult hippocampus.

    Helena Frielingsdorf, Daniel R Simpson, Leon J Thal & Donald P Pizzo, 2007, I : Neurobiology of Disease. 26, 1, s. 47-55

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  69. Re-evaluation of mitochondrial permeability transition as a primary neuroprotective target of minocycline.

    Roland Månsson, Magnus Hansson, Saori Morota, Hiroyuki Uchino, Christine Ekdahl Clementson & Eskil Elmer, 2007, I : Neurobiology of Disease. 25, s. 198-205

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  70. Soluble adhesion molecules and angiotensin-converting enzyme in dementia.

    Henrietta Nielsen, Elisabet Londos, Lennart Minthon & Sabina Janciauskiene, 2007, I : Neurobiology of Disease. 26, s. 27-35

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  71. Testicular degeneration in Huntington disease

    Jeremy M. Van Raamsdonk, Zoe Murphy, David M. Selva, Reza Hamidizadeh, Jacqueline Pearson, Åsa Petersén, Maria Björkqvist, Cameron Muir, Ian R. Mackenzie, Geoffrey L. Hammond, A. Wayne Vogl, Michael R. Hayden & Blair R. Leavitt, 2007, I : Neurobiology of Disease. 26, 3, s. 512-520

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  72. 2006
  73. Genetically determined susceptibility to neurodegeneration is associated with expression of inflammatory genes

    Maria Swanberg, Kristina Duvefelt, Margarita Diez, Jan Hillert, Tomas Olsson, Fredrik Piehl & Olle Lidman, 2006, I : Neurobiology of Disease. 24, 1, s. 67-88 22 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  74. Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia.

    Thomas Carlsson, Christian Winkler, Martin Lundblad, Angela Cenci Nilsson, Anders Björklund & Deniz Kirik, 2006, I : Neurobiology of Disease. 21, 3, s. 657-668

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  75. Prostaglandin E(2) and BDNF levels in rat hippocampus are negatively correlated with status epilepticus severity: No impact on survival of seizure-generated neurons.

    Maria Antonietta Ajmone-Cat, Robert Iosif, Christine Ekdahl Clementson, Zaal Kokaia, Luisa Minghetti & Olle Lindvall, 2006, I : Neurobiology of Disease. 23, 1, s. 23-35

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  76. The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat.

    Emma Lane, C Winkler, Patrik Brundin & Angela Cenci Nilsson, 2006, I : Neurobiology of Disease. 22, 2, s. 334-345

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  77. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression.

    Matthew Maingay, Marina Romero-Ramos, Manolo Carta & Deniz Kirik, 2006, I : Neurobiology of Disease. 23, 3, s. 522-532

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  78. 2005
  79. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses

    Claudia G. Almeida, Davide Tampellini, Reisuke H. Takahashi, Paul Greengard, Michael T. Lin, Eric M. Snyder & Gunnar K. Gouras, 2005 nov, I : Neurobiology of Disease. 20, 2, s. 187-198

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  80. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice

    T M Malm, M Koistinaho, M Parepalo, T Vatanen, Andreas Ooka, Stefan Karlsson & J Koistinahoa, 2005, I : Neurobiology of Disease. 18, 1, s. 134-142

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  81. Cystatin C modulates neurodegeneration and neurogenesis following status epilepticus in mouse

    T J Pirttila, K Lukasiuk, Katarina Håkansson, Anders Grubb, Magnus Abrahamson & A Pitkanen, 2005, I : Neurobiology of Disease. 20, 2, s. 241-253

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  82. Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunction.

    Ruben Smith, Åsa Petersén, Gillian P Bates, Patrik Brundin & Jia-Yi Li, 2005, I : Neurobiology of Disease. 20, 3, s. 673-684

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  83. Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors.

    David P D Woldbye, Avtandil Nanobashvili, Andreas Toft Sörensen, Henriette Husum, Tom G Bolwig, Gunnar Sørensen, Patrik Ernfors & Merab Kokaia, 2005, I : Neurobiology of Disease. 20, 3, s. 760-772

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  84. Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice.

    Joana Gil, Paul Mohapel, Ines Araujo, Natalija Popovic, Jia-Yi Li, Patrik Brundin & Åsa Petersén, 2005, I : Neurobiology of Disease. 20, 3, s. 744-751

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  85. 2004
  86. A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function.

    Martin Lundblad, B Picconi, Hanna Lindgren & Angela Cenci Nilsson, 2004, I : Neurobiology of Disease. 16, 1, s. 110-123

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  87. Effects of pulsatile L-DOPA treatment in the double lesion rat model of striatonigral degeneration (multiple system atrophy)

    N Stefanova, Martin Lundblad, F Tison, W Poewe, Angela Cenci Nilsson & GK Wenning, 2004, I : Neurobiology of Disease. 15, 3, s. 630-639

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  88. Status epilepticus severity influences the long-term outcome of neurogenesis in the adult dentate gyrus.

    Paul Mohapel, Christine Ekdahl Clementson & Olle Lindvall, 2004, I : Neurobiology of Disease. 15, 2, s. 196-205

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  89. Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia

    C Konradi, Jenny Westin, Manolo Carta, ME Eaton, Katarzyna Kuter, A Dekundy, Martin Lundblad & Angela Cenci Nilsson, 2004, I : Neurobiology of Disease. 17, 2, s. 219-236

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  90. 2003
  91. Death mechanisms in status epilepticus-generated neurons and effects of additional seizures on their survival.

    Christine Ekdahl Clementson, Changlian Zhu, Sara Bonde, Ben A Bahr, Klas Blomgren & Olle Lindvall, 2003, I : Neurobiology of Disease. 14, 3, s. 513-523

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  92. Kindling alters entorhinal cortex-hippocampal interaction by increased efficacy of presynaptic GABA(B) autoreceptors in layer III of the entorhinal cortex

    T Gloveli, J Behr, T Dugladze, Zaal Kokaia, Merab Kokaia & U Heinemann, 2003, I : Neurobiology of Disease. 13, 3, s. 203-212

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  93. Targeted expression of BCL-2 attenuates MPP+ but not 6-OHDA induced cell death in dopaminergic neurons

    KL O'Malley, J Liu, Julie Lotharius & W Holtz, 2003, I : Neurobiology of Disease. 14, 1, s. 43-51

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  94. 2002
  95. Evidence for Dysfunction of the Nigrostriatal Pathway in the R6/1 Line of Transgenic Huntington's Disease Mice.

    Åsa Petersén, Zoe Puschban, Julie Lotharius, B NicNiocaill, P Wiekop, W T O'Connor & Patrik Brundin, 2002, I : Neurobiology of Disease. 11, 1, s. 134-146

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  96. Neuropathological and behavioral consequences of adeno-associated viral vector-mediated continuous intrastriatal neurotrophin delivery in a focal ischemia model in rats.

    Gunnar Andsberg, Zaal Kokaia, Ronald L Klein, Nicholas Muzyczka, Olle Lindvall & Ronald J Mandel, 2002, I : Neurobiology of Disease. 9, 2, s. 187-204

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  97. 2001
  98. Alterations of Akt1 (PKBalpha) and p70(S6K) in transient focal ischemia

    S Janelidze, BIng-Ren Hu, P Siesjö & B K Siesjö, 2001 feb, I : Neurobiology of Disease. 8, 1, s. 147-154

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  99. Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of L-DOPA-induced dyskinesia

    P. A. Johansson, M. Andersson, K. E. Andersson & M. A. Cenci, 2001, I : Neurobiology of Disease. 8, 2, s. 220-239 20 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  100. 1997
  101. Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease

    Anders Björklund, Carl Rosenblad, Christian Winkler & Deniz Kirik, 1997, I : Neurobiology of Disease. 4, 3-4, s. 186-200

    Forskningsoutput: TidskriftsbidragÖversiktsartikel